Headlines

UK MHRA approves J&J's (JNJ) nipocalimab for the treatment of generalised myasthenia gravis

Newsquawk Staff ·

UK MHRA approves J&J's (JNJ) nipocalimab for the treatment of generalised myasthenia gravis.

Related headlines